Cargando…
Effectiveness of temozolomide combined with whole brain radiotherapy for non‐small cell lung cancer brain metastases
BACKGROUND: We performed a retrospective analysis to compare the efficacy of whole brain radiotherapy (WBRT) combined with temozolomide (TMZ) versus WBRT alone as first‐line treatment for brain metastases (BM). METHODS: Seventy‐eight non‐small cell lung cancer patients with BM were observed, includi...
Autores principales: | Zhu, Ying, Fu, Lei, Jing, Wang, Guo, Dong, Kong, Li, Yu, Jinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119610/ https://www.ncbi.nlm.nih.gov/pubmed/29947170 http://dx.doi.org/10.1111/1759-7714.12795 |
Ejemplares similares
-
Meta‐analysis of whole‐brain radiotherapy plus temozolomide compared with whole‐brain radiotherapy for the treatment of brain metastases from non‐small‐cell lung cancer
por: Xin, Yong, et al.
Publicado: (2018) -
The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases
por: Deng, Xia, et al.
Publicado: (2017) -
Response and safety of whole‐brain radiotherapy plus temozolomide for patients with brain metastases of non‐small‐cell lung cancer: A meta‐analysis
por: Han, Jianguo, et al.
Publicado: (2021) -
Temozolomide plus whole brain radiotherapy for the treatment of non-small-cell lung cancer patients with brain metastases: A protocol of an updated systematic review and meta-analysis
por: Duan, Hua, et al.
Publicado: (2020) -
Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis
por: Zheng, Mao-hua, et al.
Publicado: (2016)